News & Updates

Veterans with higher traumatic brain injury predisposed to subsequent brain cancer

21 Feb 2024

Veterans of Iraq and Afghanistan who sustained moderate/severe and penetrating traumatic brain injury (TBI) are at increased risk of developing brain cancer, as shown in a study.

Veterans with higher traumatic brain injury predisposed to subsequent brain cancer

21 Feb 2024

5-year survival more likely in mBCC patients with nodal vs distant metastasis

21 Feb 2024

Among patients with metastatic basal cell carcinoma (mBCC), those with nodal disease appear to have a higher chance of remission, while individuals with distant metastasis tend to have persistent disease and subsequently die from it, a recent study reveals. However, the survival rates at 5 years surpass 50 percent even for those with stage IV disease.

5-year survival more likely in mBCC patients with nodal vs distant metastasis

21 Feb 2024

Breast cancer research at UNM boosted with the Wellcome Trust Career Development Award

21 Feb 2024 by

The Wellcome Trust Career Development Award amounting to RM11.3 million has been granted to Associate Professor Dr Ho Weang Kee, Ph.D, who leads a research program on breast cancer co-hosted by University of Nottingham Malaysia (UNM) and Cancer Research Malaysia.

Breast cancer research at UNM boosted with the Wellcome Trust Career Development Award

21 Feb 2024

Androgen receptor activation holds promise in ER+/HER2- breast cancer

18 Feb 2024

The oral selective androgen receptor modulator enobosarm shows activity against ER-positive, HER2-negative advanced breast cancer, according to a phase II trial.

Androgen receptor activation holds promise in ER+/HER2- breast cancer

18 Feb 2024

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

16 Feb 2024 by

In Asian patients with esophageal squamous cell carcinoma (ESCC), adding the TIGIT inhibitor tiragolumab and PD-L1 inhibitor atezolizumab to chemotherapy improved all outcomes in the phase III SKYSCRAPER-08 trial.

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

16 Feb 2024

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

15 Feb 2024

Exposure to potassium-competitive acid blockers (PCABs) may heighten the risk of developing gastric cancer after successful treatment for Helicobacter pylori infection, according to a study.

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

15 Feb 2024

Cancer risk reduced a decade after smoking cessation

15 Feb 2024

For ex-smokers, the risk of cancer appears to significantly decrease 10 years after quitting, according to a study from Korea.

Cancer risk reduced a decade after smoking cessation

15 Feb 2024

Smoking raises risk of death in early-stage melanoma

13 Feb 2024

Smokers who have received a diagnosis of early-stage melanoma are at increased risk of death, according to a study.

Smoking raises risk of death in early-stage melanoma

13 Feb 2024

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024 by

In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024

AI model improves thyroid cancer diagnosis

12 Feb 2024

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

AI model improves thyroid cancer diagnosis

12 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Veterans with higher traumatic brain injury predisposed to subsequent brain cancer

Veterans with higher traumatic brain injury predisposed to subsequent brain cancer

5-year survival more likely in mBCC patients with nodal vs distant metastasis

5-year survival more likely in mBCC patients with nodal vs distant metastasis

Breast cancer research at UNM boosted with the Wellcome Trust Career Development Award

Breast cancer research at UNM boosted with the Wellcome Trust Career Development Award

Androgen receptor activation holds promise in ER+/HER2- breast cancer

Androgen receptor activation holds promise in ER+/HER2- breast cancer

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Cancer risk reduced a decade after smoking cessation

Cancer risk reduced a decade after smoking cessation

Smoking raises risk of death in early-stage melanoma

Smoking raises risk of death in early-stage melanoma

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

AI model improves thyroid cancer diagnosis

AI model improves thyroid cancer diagnosis